Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

David Baranano (NPI 1407992050)

Field	Value
Entity Type	Individual
Organization	David Baranano
Address	6569 N Charles St Ste 605
City	Baltimore
State	MD
ZIP	21204
Taxonomy	Ophthalmology Physician
NPI Enumerated	January 30, 2007

Payer Source	Total Paid
Medicare	$4.2M
Medicaid	$0

Key Findings

DAVID BARANANO (Ophthalmology Physician) is a long‑tenured NPI registrant (2007-01-30; ~19 years ago) with Total Medicare revenue: $4.2M and no Medicaid billing on file. The absence of any Medicaid billing makes this effectively a single‑payer (Medicare) Medicare-funded practice at the dataset level, which concentrates revenue and contracting exposure on Medicare reimbursement patterns rather than a mixed Medicaid/Medicare payer strategy.

Revenue is highly concentrated in a small number of Medicare codes: the precomputed top 3 Medicare codes by revenue account for 85.2% of this provider's total Medicare revenue. Those top three — J0178 ($2.4M, 56.2%), J2777 ($1M, 23.8%), and 67028 ($218K, 5.2%) — dominate the income profile and indicate a narrow revenue base centered on intravitreal drug therapy and the separate intravitreal injection procedure.

The code mix and volumes point to a retina‑focused, injection‑centric practice model. High revenue and claim counts for J0178 and J2777 plus a substantial count for J2778 and small use of J9035 indicate routine administration of anti‑VEGF and related intravitreal biologics, while heavy use of 67028 reflects many isolated intravitreal injection encounters.

Competitive standing for retinal injections is above typical national activity in multiple measures: J0178 ranks #117 of 3204 providers nationally (96th percentile; notably above typical national volume for this code) and 67028 ranks #304 of 4255 (93th percentile; notably above typical national volume for this code), signaling that this provider is a high‑volume national performer for aflibercept and intravitreal injections. By contrast, J2777 ranks #227 of 2039 (89th percentile; typical, unremarkable volume for this code), indicating strong but less exceptional faricimab activity relative to peers.

Ambulatory imaging and follow‑up visit codes are disproportionately frequent relative to national peers, supporting a high‑throughput injection workflow. 92134 (3.7K claims, $117.2K revenue, 2.8%) ranks #190 of 26868 providers nationally (99th percentile; extreme outlier) and 92014 (1.5K claims, $139.4K revenue, 3.3%) ranks #620 of 35415 providers nationally (98th percentile; extreme outlier), which together imply routine, repeated OCT monitoring and frequent established patient visits consistent with ongoing anti‑VEGF treatment paradigms.

There is measurable surgical retinal activity alongside the procedural/injection practice. Codes such as 67042 ($21.7K revenue, 23 claims) rank #434 of 1087 providers (57th percentile; typical) and 67108 ($16.8K revenue, 17 claims) ranks #309 of 706 providers (52th percentile; typical), indicating the provider performs some vitreoretinal surgeries but at mid‑range volumes relative to surgical retina specialists.

Evaluation/management coding shows above‑typical outpatient visit volumes for an ophthalmology specialty practice. Codes like 99213 (969 claims, $69.8K revenue) rank #6929 of 457151 providers nationally (98th percentile; extreme outlier) and 99204 (337 claims, $42.8K revenue) ranks #867 of 227068 providers nationally (100th percentile; extreme outlier), suggesting the practice combines high injection throughput with substantial face‑to‑face E/M encounters for new and established patients.

Implications for network and payer strategy: because Total Medicare revenue: $4.2M is the sole reported public payer revenue stream and because the business is concentrated in a small set of high‑percentile retinal/injection codes, the provider is operationally vulnerable to changes in Medicare drug reimbursement, coverage policies, or shifts in utilization patterns. Payer negotiations, utilization management, or population shifts that affect anti‑VEGF use would likely materially affect this provider's revenue given the 85.2% concentration in the top three codes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,420	$690	$2.4M
J2777	Injection, faricimab‑svoa, 0.1 mg	34,500	$30	$1M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,180	$100	$218K
J2778	Injection, ranibizumab, 0.1 mg	780	$180	$142K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,500	$90	$139.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,660	$30	$117.2K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	970	$70	$69.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	340	$130	$42.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	350	$90	$32.8K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	20	$940	$21.7K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

David Baranano — 3 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	6	100	950	$690	$887.3K
J2777	9	70	8,520	$30	$487.3K
J2778	21	50	650	$180	$207.8K
67028	14	120	700	$100	$101.5K
92014	45	620	210	$90	$44K
67042	11	30	20	$1,060	$25.4K
99214	2,627	10,270	150	$90	$24.1K
67036	7	20	20	$960	$22K
92235	43	90	70	$110	$19.5K
92134	14	490	110	$30	$17.3K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with David Baranano, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Raymond Sjaarda	MD	Ophthalmology Physician	$4.2M	$0
John Thompson	MD	Ophthalmology Physician	$3.9M	$0

Nearby Providers

Other providers in the same ZIP code as David Baranano, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Baltimore County Public Schools	MD	Local Education Agency (LEA)	$0	$102.7M
Gilchrist Hospice Care Inc.	MD	Inpatient Hospice	$0	$60.7M
Sheppard Pratt Physicians, P.A.	MD	Psychiatry Physician	$0	$17.3M
Greater Baltimore Medical Center, Inc.	MD	General Practice Physician	$0	$9.4M
Mei Tang	MD	Medical Oncology Physician	$6.9M	$0
Patient First Maryland Medical Group PLLC	MD	Family Medicine Physician	$0	$6.8M
University Of Maryland St. Joseph Medical Group, LLC	MD	General Practice Physician	$0	$6.2M
Sheppard Pratt Physicians PA	MD	Mental Health Counselor	$0	$5.7M
Baltimore County Deparment Of Health	MD	Public Health or Welfare Agency	$0	$5.2M
Dulaney Eye Institute, LLC	MD	Ambulatory Surgical Clinic/Center	$3.1M	$503.5K

David Baranano — Billing Profile & Reimbursement Data

Sign up for David Baranano — Billing Profile & Reimbursement Data policy alerts

David Baranano — Billing Profile & Reimbursement Data

Sign up for David Baranano — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References